The included studies should meet the following inclusion criteria: participants (patients with GCTB), intervention (preoperative denosumab followed by curettage), control (curettage only), outcome (local recurrence), and study design (retrospective or prospective studies). The following studies were excluded: case reports, reviews, animal or cell experiments, inefficient data, non-English language, or duplicated patients.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.